These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26519964)

  • 21. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    Epstein JI
    J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes.
    Mearini L; Nunzi E; Bini V; Lepri L; Bruno R; Porena M
    Urologia; 2014; 81(2):125-32. PubMed ID: 24474543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update.
    Yossepowitch O; Briganti A; Eastham JA; Epstein J; Graefen M; Montironi R; Touijer K
    Eur Urol; 2014 Feb; 65(2):303-13. PubMed ID: 23932439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillance.
    Bokhorst LP; Roobol MJ; Bangma CH; van Leenders GJ
    Prostate; 2017 Jul; 77(10):1137-1143. PubMed ID: 28543353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate. Practice parameters, pathologic staging, and handling radical prostatectomy specimens.
    Sakr WA; Grignon DJ
    Urol Clin North Am; 1999 Aug; 26(3):453-63, v. PubMed ID: 10494284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: possible prognostic significance.
    Valotto C; Falconieri G; Pizzolitto S; Cerruto MA; Brondani G; De Gobbi A; Zattoni F
    Arch Ital Urol Androl; 2011 Jun; 83(2):78-82. PubMed ID: 21826879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nondissection of pelvic lymph nodes does not influence the results of perineal radical prostatectomy in selected patients.
    Salomon L; Hoznek A; Lefrère-Belda MA; Bellot J; Chopin DK; Abbou CC
    Eur Urol; 2000 Mar; 37(3):297-300. PubMed ID: 10720855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of Reporting the Gleason Score at the Positive Surgical Margin Site: Analysis of 4,082 Consecutive Radical Prostatectomy Cases.
    Kates M; Sopko NA; Han M; Partin AW; Epstein JI
    J Urol; 2016 Feb; 195(2):337-42. PubMed ID: 26264998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens.
    Fine SW; Amin MB; Berney DM; Bjartell A; Egevad L; Epstein JI; Humphrey PA; Magi-Galluzzi C; Montironi R; Stief C
    Eur Urol; 2012 Jul; 62(1):20-39. PubMed ID: 22421083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
    De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
    Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.
    Hoedemaeker RF; Rietbergen JB; Kranse R; Schröder FH; van der Kwast TH
    J Urol; 2000 Aug; 164(2):411-5. PubMed ID: 10893598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer progression after anterograde radical prostatectomy for pathologic Gleason score 8 to 10 and influence of concomitant variables.
    Serni S; Masieri L; Minervini A; Lapini A; Nesi G; Carini M
    Urology; 2006 Feb; 67(2):373-8. PubMed ID: 16461088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
    BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
    Ellis CL; Partin AW; Han M; Epstein JI
    J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of perineural invasion in prostatectomy specimen in the assessment on tumor progression and prognosis].
    Zhu YJ; Wang YQ; Pan JH; Dong BJ; Xu F; Sha JJ; Xue W; Huang YR
    Zhonghua Wai Ke Za Zhi; 2016 Mar; 54(3):217-21. PubMed ID: 26932892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
    Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
    Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the pathologist in the evaluation of radical prostatectomy specimens.
    Ekici S; Ayhan A; Erkan I; Bakkaloğlu M; Ozen H
    Scand J Urol Nephrol; 2003; 37(5):387-91. PubMed ID: 14594686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.